Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Mol Sci ; 23(6)2022 Mar 21.
Article in English | MEDLINE | ID: mdl-35328790

ABSTRACT

Hereditary hearing loss (HHL) is a common genetic disorder accounting for at least 60% of pre-lingual deafness in children, of which 70% is inherited in an autosomal recessive pattern. The long tradition of consanguinity among the Qatari population has increased the prevalence of HHL, which negatively impacts the quality of life. Here, we functionally validated the pathogenicity of the c.178G>C, p.E60Q mutation in the MYO6 gene, which was detected previously in a Qatari HHL family, using cellular and animal models. In vitro analysis was conducted in HeLa cells transiently transfected with plasmids carrying MYO6WT or MYO6p.E60Q, and a zebrafish model was generated to characterize the in vivo phenotype. Cells transfected with MYO6WT showed higher expression of MYO6 in the plasma membrane and increased ATPase activity. Modeling the human MYO6 variants in zebrafish resulted in severe otic defects. At 72 h post-injection, MYO6p.E60Q embryos demonstrated alterations in the sizes of the saccule and utricle. Additionally, zebrafish with MYO6p.E60Q displayed super-coiled and bent hair bundles in otic hair cells when compared to control and MYO6WT embryos. In conclusion, our cellular and animal models add support to the in silico prediction that the p.E60Q missense variant is pathogenic and damaging to the protein. Since the c.178G>C MYO6 variant has a 0.5% allele frequency in the Qatari population, about 400 times higher than in other populations, it could contribute to explaining the high prevalence of hearing impairment in Qatar.


Subject(s)
Deafness , Hearing Loss, Sensorineural , Hearing Loss , Animals , Deafness/genetics , HeLa Cells , Hearing Loss/genetics , Hearing Loss, Sensorineural/genetics , Humans , Mutation , Myosin Heavy Chains/genetics , Quality of Life , Zebrafish/genetics
2.
J Cell Physiol ; 234(1): 13-22, 2018 01.
Article in English | MEDLINE | ID: mdl-30078199

ABSTRACT

Cancer cachexia is a complex disorder that is driven by inflammation and metabolic imbalances, resulting in extreme weight loss. Adipose tissue, a main player in cancer cachexia, is an essential metabolic and secretory organ consisting of both white adipose tissue (WAT) and brown adipose tissue. Its secretory products, including adipokines and cytokines, affect a wide variety of central and peripheral organs, such as the skeletal muscle, brain, pancreas, and liver. Therefore, a combination of metabolic alterations, and systemic inflammation dysregulation of both anti-inflammatory and proinflammatory modulators contribute toward adipose tissue wasting in cancer cachexia. Growing evidence suggests that, during cancer cachexia, WAT undergoes a browning process, resulting in increased lipid mobilization and energy expenditure. In this review, we have summarized the characteristics of cancer cachexia and WAT browning. Furthermore, this review describes how adipose tissue becomes inflamed in cancer, shedding light on the combinatorial action of multiple secreted macromolecules, cytokines, hormones, and tumor mediators on adipose tissue dysfunction. We also highlight the inflammatory responses, energy utilization defects, and molecular mechanisms underlying the WAT dysfunction and browning in cancer cachexia. Further, the actual mechanisms behind the loss of adipose tissue are unknown, but have been attributed to increased adipocyte lipolysis, systemic inflammation, and apoptosis or reduced lipogenesis. The understanding of adipose tissue dysfunction in cancer cachexia will hopefully promote the development of new therapeutic approaches to prevent or treat this wasting syndrome.


Subject(s)
Adipose Tissue, Brown/metabolism , Adipose Tissue, White/metabolism , Cachexia/metabolism , Neoplasms/metabolism , Adipokines/genetics , Adipokines/metabolism , Adipose Tissue, Brown/pathology , Adipose Tissue, White/pathology , Brain/metabolism , Brain/pathology , Cachexia/complications , Cachexia/genetics , Cachexia/pathology , Cytokines/genetics , Cytokines/metabolism , Humans , Inflammation/metabolism , Inflammation/pathology , Lipid Metabolism/genetics , Liver/metabolism , Liver/pathology , Muscle, Skeletal/metabolism , Muscle, Skeletal/pathology , Neoplasms/complications , Neoplasms/genetics , Neoplasms/pathology , Pancreas/metabolism , Pancreas/pathology
3.
J Cell Sci ; 129(13): 2548-58, 2016 07 01.
Article in English | MEDLINE | ID: mdl-27173493

ABSTRACT

Ca(2+)-activated Cl(-) channels (CaCCs) play important physiological functions in epithelia and other tissues. In frog oocytes the CaCC Ano1 regulates resting membrane potential and the block to polyspermy. Here, we show that Ano1 expression increases the oocyte surface, revealing a novel function for Ano1 in regulating cell morphology. Confocal imaging shows that Ano1 increases microvilli length, which requires ERM-protein-dependent linkage to the cytoskeleton. A dominant-negative form of the ERM protein moesin precludes the Ano1-dependent increase in membrane area. Furthermore, both full-length and the truncated dominant-negative forms of moesin co-localize with Ano1 to the microvilli, and the two proteins co-immunoprecipitate. The Ano1-moesin interaction limits Ano1 lateral membrane mobility and contributes to microvilli scaffolding, therefore stabilizing larger membrane structures. Collectively, these results reveal a newly identified role for Ano1 in shaping the plasma membrane during oogenesis, with broad implications for the regulation of microvilli in epithelia.


Subject(s)
Chloride Channels/metabolism , Microfilament Proteins/genetics , Oocytes/metabolism , Oogenesis/genetics , Animals , Cell Membrane/genetics , Cell Membrane/metabolism , Chloride Channels/genetics , Cytoskeleton/genetics , Cytoskeleton/metabolism , Epithelium/growth & development , Epithelium/metabolism , Gene Expression Regulation, Developmental , Microfilament Proteins/metabolism , Microvilli/genetics , Oocytes/growth & development , Protein Interaction Maps/genetics , Xenopus laevis/genetics , Xenopus laevis/growth & development
SELECTION OF CITATIONS
SEARCH DETAIL
...